Patterns of positive specimen margins and detectable prostate specific antigen after radical perineal prostatectomy
- PMID: 7536268
Patterns of positive specimen margins and detectable prostate specific antigen after radical perineal prostatectomy
Erratum in
- J Urol 1995 Aug;154(2 Pt 1):538
Abstract
Positive specimen margins and detectable postoperative prostate specific antigen (PSA) levels were analyzed after 200 consecutive radical perineal prostatectomies for clinical stages T1 and T2 adenocarcinoma of the prostate. Clinical parameters that correlated with lymph node metastases in concomitant pelvic lymphadenectomies were also noted. At a mean followup of 35 months 79% of the patients had undetectable PSA levels. Step-section pathological analysis of specimens obtained by either nerve sparing or extended radical modifications revealed that 41% of the tumors were organ confined and 56% had negative margins. Selective sacrifice of the posterolateral periprostatic fascia and the enclosed neurovascular bundle achieved negative margins and undetectable PSA levels despite capsular penetration in 15% of all patients. Of all positive margins with the perineal approach, solitary positive apical and posterolateral margins were infrequent (7% and 16%, respectively) but solitary positive anterior margins were more so (25%). Of those positive anterior margins 41% appeared to be artifactual and 45% might have been eliminated by avoiding avulsion of the puboprostatic ligaments. Pelvic lymphadenectomy could have been eliminated in 58% of the patients (clinical stage T2b or less, biopsy Gleason score 6 or less and PSA level 11 or less, for a node negative predictive value of 99%).
Comment in
-
Prostate cancer diagnosis.J Urol. 1995 May;153(5):1570-1. doi: 10.1016/s0022-5347(01)67463-9. J Urol. 1995. PMID: 7536269 No abstract available.
Similar articles
-
External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.Cancer J Sci Am. 1997 Mar-Apr;3(2):78-87. Cancer J Sci Am. 1997. PMID: 9099457
-
Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.Urology. 1996 Aug;48(2):249-60. doi: 10.1016/S0090-4295(96)00167-7. Urology. 1996. PMID: 8753737
-
The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.J Urol. 2000 Jan;163(1):174-8. J Urol. 2000. PMID: 10604340 Clinical Trial.
-
No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer.Urology. 2004 Mar;63(3):528-31. doi: 10.1016/j.urology.2003.09.064. Urology. 2004. PMID: 15028451 Review.
-
Management of patients with positive surgical margins following radical prostatectomy.Urol Clin North Am. 1994 Nov;21(4):717-23. Urol Clin North Am. 1994. PMID: 7526517 Review.
Cited by
-
What's a man to do? Treatment options for localized prostate cancer.Can Fam Physician. 2004 Jan;50:65-72. Can Fam Physician. 2004. PMID: 14761106 Free PMC article. Review.
-
Radical perineal prostatectomy: a more optimal treatment approach than laparoscopic radical prostatectomy in obese patients?Rev Urol. 2005 Winter;7(1):48-52. Rev Urol. 2005. PMID: 16985806 Free PMC article.
-
Impact of capsular incision on biochemical recurrence after radical perineal prostatectomy.Prostate Cancer Prostatic Dis. 2010 Mar;13(1):28-33. doi: 10.1038/pcan.2009.19. Epub 2009 Jun 2. Prostate Cancer Prostatic Dis. 2010. PMID: 19488066 Free PMC article.
-
Evaluating radical prostatectomy specimens: therapeutic and prognostic importance.Virchows Arch. 1997 Jan;430(1):1-16. doi: 10.1007/BF01008010. Virchows Arch. 1997. PMID: 9037309 Review.
-
Adjuvant radiation therapy after radical prostatectomy: when is it indicated?Curr Urol Rep. 2009 May;10(3):194-8. doi: 10.1007/s11934-009-0033-8. Curr Urol Rep. 2009. PMID: 19371476 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous